7 / 21
Page 41
Notes:
conferenceseries
.com
Volume 7, Issue 4 (Suppl)
J Clin Exp Pathol, an open access journal
ISSN: 2161-0681
Euro Pathology 2017
August 02-03, 2017
13
th
EUROPEAN PATHOLOGY CONGRESS
August 02-03, 2017 Milan, Italy
Pancreatic neuroendocrine neoplasms: Review of clinically relevant information
Jeannelyn Estrella
University of Texas MD Anderson Cancer Center, USA
P
ancreatic neuroendocrine neoplasms (PanNETs) are rare, representing approximately 3% of primary pancreatic neoplasms,
although their incidence has risen sharply in the United States, increasing more than 100% over the past three decades. In
the past, classification of PanNETs has been fraught with different nomenclature and multiple grading and staging systems. The
2010 WHO Classification of Tumours of the Digestive System and the 7
th
edition of AJCC Cancer Staging Manual have tried to
address these issues, however, controversies still exist. This lecture will address the current grading and staging systems, issues
encountered in everyday practice, clinical significance and future direction.
Biography
Jeannelyn Estrella has completed her MD at University of California, San Diego School of Medicine; Anatomic Pathology Residency at New York Presbyterian–Weill
Cornell Medical College in New York and; Oncologic Pathology Fellowship and Gastrointestinal tract and Liver pathology Fellowship at MD Anderson in Houston,
TX. She is an Associate Professor at MD Anderson in the GI and Liver section. She is the primary Investigator, Co-primary Investigator or Collaborator in six
institutional or national research grants. She has published 43 papers in peer-reviewed journals.
JSEstrella@mdanderson.orgJeannelyn Estrella, J Clin Exp Pathol 2017, 7:4(Suppl)
DOI: 10.4172/2161-0681-C1-037